(No ratings)
Dr. Zachary Michael Grinspan, MD, MS is a pediatric neurologist in New York, NY specializing in pediatric neurology. Dr. Zachary Michael Grinspan, MD, MS is affiliated with NewYork-Presbyterian and Child Neurology at NewYork-Presbyterian/Weill Cornell Medical Center.
505 East 70th Street Helmsley Tower, 3rd Floor
New York, NY 10021
Big Brook, NY 10021
He is certified by the Neurology With Special Qualifications In Child Neurology Pediatrics and has a state license in New York.
Board Certification: Neurology With Special Qualifications In Child Neurology Pediatrics
Licensed In: New York
Dr. Zachary Michael Grinspan, MD, MS is associated with these hospitals and organizations:
Dr. Zachary Michael Grinspan, MD, MS appears to accept the following insurance providers: GHI, Empire Blue Cross/Blue Shield, Oxford Health Plans, Health Insurance Plan of NY (HIP), Aetna - NYP, CIGNA, AETNA, Empire Blue Cross/Blue Shield Healthplus, United Healthcare, Health Insurance Plan of New York (HIP), Group Health Incorporated (GHI), Aetna, EmblemHealth, Empire BlueCross BlueShield, United Healthcare, Oxford Health Plans and VNSNY CHOICE.
According to our sources, Dr. Zachary Michael Grinspan, MD, MS accepts the following insurance providers:
Dr. Zachary Michael Grinspan, MD, MS does not have any reviews yet, be the first to leave a review of Dr. Zachary Michael Grinspan, MD, MS here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Zachary Michael Grinspan, MD, MS. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Cyberonics, Inc. |
$137
VNS Therapy $137 |
---|---|
Lundbeck LLC |
$58
ONFI $58 |
UCB Biosciences Inc. |
$44
$44 |
Food and Beverage | $240 |
---|
Dr. Zachary Michael Grinspan, MD, MS has received 1 research payments totaling $44,043.
Dr. Zachary Grinspan's area of specialization is pediatric neurology. Dr. Grinspan is professionally affiliated with NewYork-Presbyterian. According to Yext, he is not acceping new patients at this time.